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Leishmania species cause a spectrum of human diseases in tropical and subtropical regions of
the world. We have sequenced the 36 chromosomes of the 32.8-megabase haploid genome of
Leishmania major (Friedlin strain) and predict 911 RNA genes, 39 pseudogenes, and 8272
protein-coding genes, of which 36% can be ascribed a putative function. These include genes
involved in host-pathogen interactions, such as proteolytic enzymes, and extensive machinery
for synthesis of complex surface glycoconjugates. The organization of protein-coding genes
into long, strand-specific, polycistronic clusters and lack of general transcription factors in the
L. major, Trypanosoma brucei, and Trypanosoma cruzi (Tritryp) genomes suggest that the
mechanisms regulating RNA polymerase II–directed transcription are distinct from those
operating in other eukaryotes, although the trypanosomatids appear capable of chromatin
remodeling. Abundant RNA-binding proteins are encoded in the Tritryp genomes, consistent
with active posttranscriptional regulation of gene expression.
Infection with pathogenic Leishmania results in a spectrum of human diseases, termed the
leishmaniases, with an annual incidence of 2 million cases in 88 countries (1). Leishmania
parasites are transmitted by sand flies as proliferative promastigotes, which differentiate into
nondividing metacyclic forms before inoculation into the vertebrate host and phagocytosis by
macrophages. The metacyclics subsequently differentiate into amastigotes, which proliferate
in the phagolysosome, leading to macrophage lysis and serial infection of other macrophages
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(2). The outcome of infection is determined by the infecting species, host genetic factors, and
the immune response.
Old World Leishmania (L. donovani and L. major groups) have 36 chromosome pairs (0.28 to
2.8 Mb) (3), whereas New World species have 34 or 35, with chromosomes 8+29 and 20+36
fused in the L. mexicana group and 20+34 in the L. braziliensis group (4). Gene order and
sequence are highly conserved among the ∼30 Leishmania species (5). The genome sequence
of L. major MHOM/IL/81/Friedlin was determined on a chromosome-by-chromosome basis.
Here we present the structure and content of the L. major genome, with an emphasis on
fundamental molecular processes such as chromatin remodeling, transcription, RNA
processing, translation, posttranslational modification, and protein turnover. We also discuss
the synthesis of complex surface glycoconjugates that are characteristic of Leishmania species
and essential at the host-parasite interface. Discussion of cytoskeleton, metabolism, and
transport can be found in the accompanying description of the Trypanosoma brucei genome
(6), while signaling pathways, DNA repair, recombination, and replication are discussed in the
Trypanosoma cruzi article (7).
Genome structure and content
The 32,816,678–base pairs (bp) in the current assembly (version 5.2) were obtained by shotgun
sequencing large-insert clones and purified chromosomal DNA. A single contiguous sequence
was generated for each of the 36 chromosomes (Table 1, Plate 4, and table S1), although the
“right” end of chromosome 8 lacks a small amount of subtelomeric sequence and telomeric
hexamer repeats. The accuracy of sequence assemblies was assessed by comparison to an
optical map (8), with only a few discrepancies occurring in regions of repetitive sequence.
Although the genome is partially aneuploid (9) and there are three large-scale allelic differences
(table S1), there are very few (<0.1%) sequence polymorphisms, contrasting notably with the
genomes of T. brucei (6) and T. cruzi (7).
Analysis of the L. major sequence using several algorithms (10) predicts 911 RNA genes, 39
pseudogenes, and 8272 protein-coding genes (Table 1), of which 3083 cluster into 662 putative
families of related genes (table S2). Most of the smaller (<10 members) gene families appear
to have arisen from tandem gene duplication, whereas most members of larger (>10 members)
families have multiple loci containing single genes and/or tandem arrays (Table 2); many of
the latter contain Leishmania-specific genes.
L. major telomeres are heterogeneous in structure and quite distinct from those in T. brucei
and T. cruzi (11). The extremity of each L. major chromosome contains the tripartite “repeated-
repeat” structure previously reported (12). Six telomeres contain 0.7 to 25 kb of the
Leishmania subtelomeric repeat (LST-R) sequences (9) between the TAS region and the first
gene. Five additional groups of telomeres share varying amounts of sequence, including two
cases (chromosome 17 and chromosome 10) in which the ends of a single chromosome contain
the same subtelomeric sequence.
Most L. major genes have orthologs in the T. brucei and T. cruzi genomes (11); however, 910
L. major genes have no orthologs in the other two Tritryp genomes, 74 orthologous groups
contain only L. major and T. brucei genes, and 482 orthologous groups contain genes from
only L. major and T. cruzi. These “Leishmania-restricted” genes are randomly distributed in
the genome with respect to relative chromosomal position or distance from the telomere,
although some are adjacent to strand-switch regions (see below) and synteny break points
(11). Although some Leishmania-restricted genes are responsible for key metabolic differences
between Leishmania and T. brucei and T. cruzi (e.g., certain peptidases, transporters, and
glycoconjugate biosynthesis components), most (68%) have unknown functions. Of particular
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interest, however, are two closely related genes (LmjF33.1740 and LmjF33.1750), whose
predicted proteins both contain a macrophage migration inhibition factor (MIF) domain and
show 30 to 40% identity to MIF homologs from several other organisms (including other
Leishmania species). The L. major MIFs are predicted to retain the tautomerase activity found
in other species, but lack the thiol oxidoreductase activity found in higher eukaryotes.
Phylogenetic analysis places the Leishmania MIF genes into a bacterial clade (fig. S1). Human
MIF has been shown to activate macrophages to kill Leishmania parasites via a T helper cell
1 (TH1)–type pathway (13); the MIF homolog in the filarial worm, Brugia malayi, directs
macrophages to a TH2 pathway (14). Thus, it is tempting to speculate that Leishmania MIF
may similarly modulate the host macrophage response and promote parasite survival.
RNA genes
RNAs participate directly in several cellular processes, including DNA replication (lagging-
strand primers and telomerase RNA), splicing [spliced leader RNA (slRNA) and small nuclear
RNAs (snRNAs)], RNA processing and modification [small nucleolar RNAs (snoRNAs) and
ribonuclease P (RNaseP)], translation [ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs)],
translation regulation (microRNA and antisense RNA), and protein translocation across
membranes [signal recognition particle (SRP) or 7slRNA]. Although all three genomes encode
very similar repertoires of RNA genes, their organization differs between L. major and the two
Trypanosoma species. For example, the 28S, 18S, and 5.8S rRNA genes occur as a single large
tandem array in L. major, but in dispersed loci in several different chromosomes in T. brucei
and T. cruzi. The 5S rRNA genes are found at 11 different loci on several chromosomes in L.
major, but in a single tandem array in T. brucei and T. cruzi.
All three Tritryp genomes encode tRNAs with 45 of the 61 possible anticodons, but the number
of genes and their locations (in numerous loci of up to five genes) differ between species (table
S3). Eight of the 16 unrepresented anticodons can be covered by third-position wobble, whereas
the others require modification of cognate anticodons. Six snRNAs (U1 to U6) for RNA
splicing were found in the three genomes, generally associated with tRNA clusters. SnoRNAs
function in 2′-O-methylation (C/D snoRNAs) and pseudouridylation (H/ACA snoRNAs) of
rRNA, slRNA, and snRNA by formation of guide RNA-target duplexes. In the Tritryp
genomes, the snoRNAs are encoded by several hundred genes organized in clusters of tandem
repeats of one to five different genes in several loci on a number of different chromosomes
(table S3); most occur on the same strand as the adjacent protein-coding genes. All three
trypanosomatid genomes have a single gene encoding 7slRNA, located in a 5S rRNA/tRNA
cluster in L. major, and a tRNA/snRNA cluster in T. brucei and T. cruzi. It has been suggested
that a tRNA-like molecule found in the trypanosomatid SRP complex (15) provides (in trans)
the translation elongation arrest function normally associated with the 7SL RNA Alu domain,
which is absent in the Tritryp molecule.
Chromatin remodeling
Trypanosomatids contain multiple copies of the four core (H2A, H2B, H3, and H4) and linker
(H1) histone genes, which package chromosomal DNA into nucleosomes in eukaryotes and
regulate access by the RNA polymerase transcription complexes. Most of these genes are
clustered in discrete single tandem arrays in T. brucei and T. cruzi, but each of the gene types
occurs in two or more separate loci in L. major; dispersed single-copy variants are found in all
three genomes (table S4). The H2A variant is a homolog of the highly conserved H2A.Z, which
protects “active” chromatin from silencing in yeast (16). The H2B, H3, and H4 variants appear
to be novel, but may have roles in gene silencing, gene expression, DNA repair, and centromere
function. Centromeres have been reported in T. cruzi (17), but no homologs were found in the
Tritryps for CenH3, which is required for kinetochore assembly during mitosis. The Tritryp
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genomes encode a number of enzymes involved in histone modification (table S4) that may
influence transcription, replication, repair, and recombination. These include two families of
acetyltransferases, at least three families of methyltransferases, and all three known classes of
histone deacetylases, at least two of which are essential in T. brucei (18). Two of the
acetyltransferases have putative methyl-lysine–binding chromodomains, implying an
association with chromatin methylation. The genomes also encode at least four putative acetyl-
lysine–binding bromodomain proteins, one (in L. major and T. cruzi) with a chromatin-
associated CW-type zinc finger. The Tritryp parasites thus possess a range of chromatin-
remodeling activities typical of eukaryotes, although there are some notable differences.
Transcription
Little is known about the mechanism of transcription initiation in trypanosomatids, and only
a few promoters have been functionally analyzed (19). The chromosomes are characterized by
their unique arrangement of directional gene clusters (DGCs), previously described in L.
major (20,21) and T. brucei (22,23). The full extent of this organization is now evident. The
L. major genome is organized into 133 clusters of tens to hundreds of protein-coding genes,
with unrelated predicted functions, on the same DNA strand (Plate 4). The clusters can span
up to 1259 kb and are separated by 0.9- to 14-kb divergent or convergent strand-switch regions,
which show an unusual base composition (24). Experimental evidence suggests that
polycistronic transcription by RNA polymerase II (RNAP II) initiates bidirectionally within
the divergent strand-switch regions (21,25,26) and terminates within the convergent strand-
switch regions, which often contain tRNA, rRNA, and/or snRNA genes (26). Several long
DGCs contain intervening tRNA or snRNA genes (which are transcribed by RNAP III),
suggesting that they may represent more than one polycistron. At most chromosome ends (55
of 72 for L. major), transcription proceeds toward the telomere, and in 12 cases, the DGC
closest to the telomere is very short (one to three genes).
Eukaryotic RNAP I, II, and III contain 14, 12, and 17 protein subunits, respectively; in yeast,
five shared and six conserved polypeptides are present in all three polymerases, with all other
components specific to each complex (27,28). Tritryps have all the shared and conserved
subunits except for ABC10α and A43, but many homologs for RNAP-specific subunits are
absent (table S5 and Fig. 1). The Tritryp genomes contain two or three different genes encoding
both ABC27 and ABC23, suggesting that these subunits may not be shared by the different
RNAP complexes as they are in yeast. Tritryp RPB1 lacks the heptad repeats found in the
higher eukaryotic C-terminal domain (29). Thus, the Tritryp RNAP I, II, and III components
differ appreciably from those in other eukaryotes.
Few potential homologs of RNAP II basal transcription factors found in other eukaryotes could
be identified (table S6 and Fig. 1); the three subunits of TFIIH present also function in DNA
repair and cell cycle control (30). TRF4 (which is related to TATA-box binding protein
component of TFIID and TFIIIB) is essential for transcription by all three RNAPs (31).
Potential homologs of BTF3b, BRF, La antigen, SNAP50, and a trypanosomatid-specific SL
RNA promoter-binding factor were identified, along with four genes encoding proteins similar
to TFIIS (Fig. 1B), and a SNF2-like DNA heli-case (table S6). A systematic search for Pfam
domains relevant to gene expression revealed substantially fewer potential transcriptional
regulators in the Tritryps than in most other eukaryotes (Fig. 2). By contrast, the Tritryp
genomes contain a disproportionately higher number of proteins with CCCH-type zinc finger
domains, which are found in RNA-binding proteins (see below). These findings, along with
the polycistronic gene organization and paucity of RNAP II initiation sites, are consistent with
posttranscriptional control mechanisms being the primary determinants of Tritryp gene
expression (19).
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RNA processing
Trypanosomatid mRNA processing is distinctive: In addition to the trans-splicing of a spliced-
leader RNA to the 5′ end of almost all mRNAs, the site of polyadenylation is determined by
trans-splicing of the downstream mRNA, rather than by an AAUAAA and downstream G/U-
rich tract (32). Only four cases of cis-splicing could be identified (table S7). Two have been
previously described (33,34); the two novel examples are both hypothetical proteins that are
predicted to be capable of RNA binding. Both cis- and trans-splicing appear to be catalyzed
by the Tritryp spliceosome (35). All snRNAs (table S4) and most spliceosomal proteins (table
S8) were identified, but not all snRNP particle protein components were found. It was possible
to identify many putative Tritryp splicing regulatory proteins, including those containing
domains for 3′ splice site and branch point recognition factors, as well as several heterogeneous
nuclear RNP (hnRNP) and sarcoplasmic reticulum (SR) proteins implicated in splicing and
alternative splicing. Thus, it appears that regulation of splicing may have arisen early in
eukaryotic evolution.
There are two dissimilar Tritryp poly(A) polymerases, which may have distinct functional
roles. Homologs of the cleavage and polyadenylation specificity factor (CPF/CPSF)
complexes, conserved between yeast and mammals, are also found in the Tritryps (table S9).
However, no homologs of the CstF complex are evident, except for a possible CstF50 homolog.
In mammalian cells, CstF50 interacts with the C-terminal domain of RNAP II and provides a
link between polyadenylation and transcription initiation/termination. The absence of an
RNAP II C-terminal domain may reflect the polycistronic transcription and resultant
uncoupling of transcription termination and polyadenylation in the Tritryps.
Degradation of mRNAs is important in regulating trypanosomatid gene expression, and
appears to resemble the situation in mammals, in which the exosome plays a dominant role.
Tritryps have homologs of the deadenylation complexes, in addition to two poly(A) binding
proteins. Although homologs of decapping proteins themselves were not found, a helicase
involved in the process, and the exonucleases required to degrade decapped mRNAs, were
(table S10). The six pleckstrin homology (PH)-domain exonucleases and three S1-domain
proteins of the exosome “core” are conserved in these organisms and are essential in T.
brucei (36). However, exosome-associated proteins that confer RNA processing and
degradation specificity have not been found. The existence of nonsense-mediated mRNA decay
in trypanosomatids is uncertain, because most of the genes required in yeast have not been
identified in the Tritryp genome.
The paucity of Tritryp genes for transcriptional regulation (see above) implies a reliance on
posttranscriptional control of gene expression (19) and is consistent with the presence of
numerous genes for proteins with RNA-binding motifs. The total number of RNA recognition
motifs (RRMs) is similar in yeast and Tritryps proteins (e.g., 103 in T. brucei versus 70 in
Schizosaccharomyces pombe), but Tritryps have more small proteins with single RRMs (table
S11), which may reflect unique Tritryp functions or cooperation between proteins. The Tritryp
genomes encode ∼40 proteins with canonical CCCH-type zinc finger RNA-binding domains
(Fig. 2 and table S11C), compared to only seven in Saccharomyces cerevisiae and 12 in S.
pombe. Nearly all ∼40 Tritryp proteins have only a single CCCH domain, whereas two
domains are typically required for RNA binding in other systems. We have identified a novel
CCCH domain variant (Cx10Cx5CxH) that is occasionally found in association with a
Cx8Cx5Cx3H finger. The roles of many of these proteins, beyond RNA binding, remain to be
determined.
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Translation and co-/posttranslational modification
Most major components of the translation machinery are found in the Tritryps (table S12), with
similar copy numbers (one to seven) as observed in other lower eukaryotes. However, there
appears to be paralogous expansion of the eIF-4A gene, with 15 copies showing 30 to 57%
amino acid identity to that from S. cerevisiae, and ∼100 with <30% identity. Most contain
adenosine 5′-triphosphate (ATP)–dependent DEAD-box RNA helicase domains, implying
nucleic acid binding, perhaps for transcriptional or translational processes. There are also
numerous copies of eEF-1α, which complexes with guanosine 5′-triphosphate (GTP) and
aminoacyl-tRNAs for ribosomal A site binding during translation, but also functions in
processes such as actin binding/bundling in cytokinesis in Tetrahymena (37). Functionally, L.
major eIF-2B is predicted to also have mannose-1-phosphate guanyltransferase activity
(LmjF23.0110) (38), whereas the eEF-1B complex has trypanothione S-transferase and
peroxidase activity (39). Thus, the expanded number of potential translation factors in the
Tritryps suggests a high degree of specialization.
Protein modification within the Tritryps involves typical eukaryotic processes, including
phosphorylation, glycosylation, and lipidation for stabilization and/or activation. Several major
modifications have been well characterized and shown to be essential, namely,
glycosylphosphatidylinositol (GPI)–anchor addition, acylation (including N-myristoylation
and palmitoylation), and prenylation, all of which facilitate membrane attachment and/or
protein-protein interactions. The Tritryp genomes include a substantial number of proteins
containing motifs for putative N-myristoylation (table S13) or prenylation (table S14),
suggesting that the enzymes that catalyze these modifications may be promising drug targets,
given their large number of possible substrates.
Surface molecules
The surface of the Leishmania parasite is distinguished by the presence of a variety of novel
glycoconjugates implicated in various aspects of the infectious cycle in the sand fly and
mammalian host. These include lipophosphoglycan (LPG), glycoinositolphospholipids
(GIPLs), and membrane proteophosphoglycan (PPG), as well as glycosylated GPI-anchored
proteins (e.g., GP63, PSA-2/GP46). The secreted acid phosphatase and other PPGs also contain
similar posttranslational modifications and vary in structure, expression, and function among
Leishmania species, as well as between the Tritryps. Although genes of the ether phospholipid
synthetic pathway have been identified (6), mapping the entire LPG synthetic pathway remains
incomplete (table S15), because many of the currently identified genes appear to be novel
(40).
LPG is assembled in the lumen of the Golgi and requires the provision of activated sugars by
nucleotide sugar transporters. The LPG2 gene product transports GDP-mannose, as well as
GDP-arabinose and GDP-fucose, for LPG and phosphoglycan (PG) synthesis; and several
potential UDP-Gal transporters can be found in L. major. Other nucleotide sugar transporters
are present, but their specificity is unknown. Genes for several glycosyltransferases with likely
roles in LPG and PG synthesis have been identified, as have genes with roles in synthesis of
the LPG glycan core, PG repeating units, and species-and stage-specific PG repeat unit
modification. Many, but not all, of these genes appear to be L. major–specific, although T.
brucei and T. cruzi both contain a number of genes encoding glycosyltransferases with different
specificities (table S15). Seven genes (SCG1 to SCG7) encoding PG-galactosyltransferases
and three copies of a gene (LPG1G) encoding a possible GIPL β-galactofuranosyltransferase
have telomeric locations. Six SCG-related (SCGR) genes are found in a cluster on chromosome
2, where they are interspersed with the SCA1 and SCA2 genes, which mediate the arabinosyl
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capping of the Gal-[PG] repeat necessary for parasite midgut release during metacyclogenesis
(41). The functional significance of these nonrandom genomic locations is not yet apparent.
Sphingolipids are essential membrane components in all eukaryotic cells, and their metabolites
also function in intracellular signaling. The primary sphingolipid species in the Tritryps is
inositol phosphorylceramide (IPC), a target for drug development in pathogenic fungi, because
it is not made in mammals. Genes for most of the sphingolipid biosynthetic pathway are present
in the Tritryps, with the important exception of IPC synthase (table S16). However, this
pathway is not essential for intracellular survival, because L. major scavenges lipid precursors
from the host and remodels them to generate parasite-specific IPCs (42,43).
The zinc metallopeptidase GP63 (leishmanolysin, MSP, or PSP) is the major insect-stage
surface protein of Leishmania. It facilitates resistance to complement-mediated lysis on host
cell entry and is also implicated in receptor-mediated uptake of Leishmania (44). In L.
major, there is a tandem array of GP63 genes on chromosome 10 (some of which encode
proteins with predicted GPI-anchors), a single GP63 gene on chromosome 28, and a related
gene on chromosome 31 (table S17). T. brucei and T. cruzi both contain a tandem cluster of
GP63 genes orthologous to the L. major chromosome 10 locus, as well as five genes in two
other loci in T. brucei, and >350 (including pseudogenes) GP63-like genes in T. cruzi. Amastin
was first described as an abundant amastigote surface protein in T. cruzi, where it occurs in
tandem clusters, alternating with another putative surface protein, tuzin (45). L. major has 57
amastin genes, most of which are also located in tandem clusters on several chromosomes
(table 2), but tuzin genes are found in only three of the loci (chromosomes 8, 34, and 36). T.
brucei has only single, separate, orthologs of amastin and tuzin. All L. major amastins have
transmembrane domains; 38 have predicted signal peptides, and some also have predicted GPI-
anchors. Expression analyses in L. major and L. infantum demonstrate that some amastins are
lifecycle stage–specific, and that the expression profiles of the various orthologs are dissimilar
between these two species (46). Another large gene family that encodes GPI-anchored
glycoproteins, alternatively known as PSA-2 or GP46 (depending on the Leishmania species),
is found on chromosome 12, with five divergent copies at other loci (Table 2). The PSA-2
proteins function in macrophage binding and show structural similarity (but not sequence
identity) with the T. cruzi mucins (7); there are no closely related orthologs in T. brucei.
Proteolysis
As found in most eukaryotes, peptidases represent ∼2% of the protein-coding genes in the
Tritryps, and some have already been identified as virulence factors, vaccine candidates, and
drug targets. Peptidases are structurally and functionally diverse and are grouped according to
intrinsic evolutionary relationships (47). Only two aspartic peptidase homologs were identified
in the Tritryps: presenilin 1 and signal peptide peptidase that cleave type I and II membrane
proteins, respectively (table S18). Tritryps lack the pepsin-like aspartic peptidases (e.g.,
plasmepsins) that abound in apicomplexan parasites, but have many papain family (including
the abundant and well-studied CPB/cruzipain lysosomal enzymes and CPA, which is unique
to L. major) and calpain cysteine peptidases, as well as ubiquitin C-terminal hydrolases.
Trypanosomatids, which are the only known eukaryotes with both a proteasome (48) and a
eubacterial HslVU complex (49), also have numerous ubiquitin-conjugating enzymes,
indicative of an active nonlysosomal cytosolic protein degradation system. In addition, the
presence of two ATG4 cysteine peptidases, their potential substrate ATG8, and other ATG
genes suggests that autophagy operates in organelle and protein turnover. The Tritryps lack
caspases but contain several metacaspases, consistent with a caspase-independent cell death
mechanism (50).
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No trypsin/chymotrypsin family serine peptidases were found in Tritryps. Other serine
peptidase families are present, however, including a subtilisin-like serine peptidase with a
signal peptide and thus likely involved in the processing of secreted proteins. Other serine
peptidases identified include six putative prolyl oligopeptidase family proteins [which have
been shown to be important for cell invasion in T. cruzi (51) and are potential drug targets], a
type I signal peptidase, a 26S regulatory proteasome subunit, a nucleoporin homolog, and
several orthologs of rhomboidlike intramembrane serine peptidases, which might have
signaling functions. Although GP63 is the most abundant metallopeptidase family, especially
in T. cruzi (see above), there are 14 other families of metallopeptidases. Seven
metallopeptidases, belonging to three paralogous families, show evidence of lateral gene
transfer from prokaryotes (6), as do a putative peptidase T and a serine peptidase.
No representatives of the almost 200 mammalian peptidase inhibitors (e.g. serpins and
cystatins) were found. However, Tritryps encode inhibitors of cysteine peptidases (ICP) that
mammals seem to lack; one of these is chagasin, a potent inhibitor of cruzipain and mammalian
cathepsin-L. Recent data suggest that Leishmania ICP play an important role in host-parasite
interaction (52), whereas T. cruzi chagasin has a role in modulating parasite differentiation and
invasion of mammalian cells (53). Curiously, the Tritryps also encode inhibitors of serine
peptidases (ISPs) that are similar to ecotins, which are normally found in only a few bacterial
species, including Escherichia coli. Ecotins are inhibitors of trypsin/chymotrypsin-like serine
peptidases, which are notably absent in the Tritryps. However, because these peptidases are
abundant in both mammals and insects, ISPs very likely play an important role in host-parasite
interactions.
Implications and concluding remarks
The Tritryp genome sequences provide insights not only into the unique aspects of the biology
of these parasites, but also eukaryote evolution, given their early divergence. Key differences
from other eukaryotes include the manner in which the genome is organized into polycistronic
gene clusters, a simplified transcriptional machinery, and mRNA trans-splicing coupled with
polyadenylation. Although trypanosomatids can dynamically modify histones, implying an
early origin of chromatin regulatory pathways, they primarily rely on posttranscriptional
mechanisms for regulating gene expression. The lack of transcriptional control mechanisms is
further manifested in the use of gene duplication/amplification as a means of increasing
expression levels. Gene duplication and divergence are also exploited for the generation of
antigenic diversity, particularly in T. brucei and T. cruzi. Trypanosomatids exhibit extensive
posttranslational protein modification, especially for surface and secreted proteins, and have
substantial species-specific arrays of glycoconjugate biosynthetic enzymes. The Tritryp
genomes have much in common but display important differences (11), reflecting different
survival requirements and pathogenesis in the specific niches they exploit.
The availability of the entire genetic content of one Leishmania species provides the foundation
for the identification and in-depth functional analysis of virulence factors, critical enzymes in
key metabolic pathways, and potential vaccine candidates. All provide crucial information for
the development of new therapies for the leishmaniases. Genome sequence comparisons to
additional Leishmania strains and species, projects that are ongoing, may elucidate the
contribution of parasite factors to tropism and disease pathology.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig 1.
Trypanosomatid RNA polymerase subunits and transcription factors. (A) The TRIBE-MCL
(table S2) protein families containing subunits of human RNA polymerase II (Rpb-1 to -12)
and basal transcription factors (TBP and TFII-B, -E, -F, -H) are shown as ovals and circles
respectively. Families containing Tritryp sequences are colored sepia and indicated by “+” or
“(+)” (when the Tritryp gene is not a direct ortholog), whereas families lacking Tritryp
sequences are indicated by “−” or “(−)” (when a Tritryp ortholog was detected only by BlastP
analysis). Orthologs present in other taxa are indicated by “+”. The genomes queried for each
taxon are detailed in (10). (B) Subunits of the yeast TFIIS, Elongator, Cdc73/Paf1, and Elongin
complexes are displayed in blue boxes, with the first column of the row indicating whether
Tritryp sequences with high “X”, weak “(X)”, or no “∼” similarity were detected. The
remaining columns of the row are marked as in (A); “?” indicates that the S. cerevisiae sequence
is not present in the TAP reference set.
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Fig 2.
Protein domains associated with regulation of gene expression in trypanosomatids. The Pfam
accession numbers for HMMs that match Tritryp predicted proteins are shown at the left, with
the next column indicating the total number of sequences matched in the Tritryp genomes. The
matches in individual genomes (normalized by genome size) are shown by the bar graphs,
expressed per 10,000 genes. Abbreviations: L. major (Lm); T. brucei (Tb); T. cruzi (Tc); P.
falciparum (Pf); Cryptosporidium parvum (Cp); S. pombe (Sp); S. cerevisiae (Sc); Magnaporthe
grisea (Mg); N. crassa (Nc); A. thaliana (At); C. elegans (Ce); D. melanogaster (Dm); Mus
musculus (Mm); Rattus norvegicus (Rn); H. sapiens (Hs). The two numbers immediately to the
right of the bar graphs show the maximum and minimum matches observed for all genomes,
and the next column shows the mean ± SD for the 10 free-living eukaryotes. The Pfam
description of the HMM is shown at the right, with the normalized and actual (in square
brackets) number of matches in the L. major, T. brucei, and T. cruzi genomes shown beneath.
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Table 1
Summary of the L. major genome.
Parameter Number
The genome
Size (bp) 32,816,678
G+C content (%) 59.7
Chromosomes 36
Sequence contigs 36
Percent coding 47.9
Protein-coding genes
Genes 8272
Pseudogenes 39
Mean CDS length (bp) 1901
Median CDS length (bp) 1407
G+C content (%) 62.5
Gene density (genes per Mb) 252
Intergenic regions*
Mean length (bp) 2045
G+C content (%) 57.3
RNA genes
tRNA 83
rRNA† 63
slRNA† 63
snRNA 6
snoRNA 695
srpRNA 1
*
Region between protein-coding CDS.
†
The exact number cannot be determined because of misassembly.
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Table 2
L. major Friedlin protein-coding gene families.
Family size* Gene product(s) L. major–specific Organization
† Chromosome(s)
491 Hypothetical proteins (several
annotations)
Some D Multiple
189 Kinesins/hypothetical proteins Some T+D Multiple
60 Protein kinases (several groups) Some T+D Multiple
46 Amastins Most T+TI+D 8, 31, 34, 36
32 Protein kinases (CMGC group) One D Multiple
32 PSA-2 (GP46) All T+D 12, 21, 31, 35
29 RNA helicases/eIF-4a None T+D Multiple
27 ATPase/serine peptidases None D Multiple
29 Hypothetical proteins (kinesin-like) One D Multiple
25 Protein phosphatases None T+D Multiple
25 Tuzins Some TI+D 8, 34, 36
24 Protein kinases (STE group) Some D Multiple
23 Amino acid permeases Some T+D Multiple
19 HSP83 None T+D 29, 33
18 DNA helicases Some D Multiple
18 β-tubulins None T+D 8, 21, 33
17 Hypothetical proteins (LACK) One D Multiple
17 Hypothetical proteins Some T+D 11, 13, 21, 29, 31, 36
15 Calpain-like cysteine peptidases Some T+D 4, 20, 25, 31, 36
14 HSP70 and related proteins None T+D 1, 18, 26, 28, 30, 35
14 Phosphoglycan β 1,3
galactosyltransferases
Some T+D 2, 7, 14, 21, 25, 31, 35, 36
14 Dynein heavy chain One D Multiple
14 RNA helicases None D Multiple
14 α,γ,ε-tubulins Bone T+D 13, 21, 25
13 Hypothetical proteins (PIPK-like protein) One D Multiple
13 Pteridine transporters Some T+D 4, 6, 10, 19, 35
13 Microtubule-associated proteins All T 9
13 ABC transporters/P-glycoproteins Some T+D 23, 25, 26, 31, 32, 33, 34
12 Protein kinases (NEK group) One D Multiple
12 DNAJ chaperones Some D Multiple
12 Hypothetical proteins None T+D 12
11 Long-chain fatty acid CoA ligases Some T+D 1, 13, 19, 28
11 Protein kinases (DYRK and CLK
families)
One D Multiple
11 Translation elongation factors None T+D 11, 17, 18, 34, 35
10 Cyclophilins None D Multiple
10 ABC transporters Some T+D 2, 11, 15, 27, 29
10 ATPases None T+D 4, 7, 17, 18, 33, 35
10 Clan CA, family C1 cysteine peptidases Some T+D 8, 19, 29
10 Hypothetical proteins (possible
peptidases)
None T+D 15, 16, 27
*
Families correspond to Tribe-MCL clusters (table S2) obtained using inflation value 4, and BlastP cut-off of e−15. Under these conditions, more divergent,
but nonetheless functionally related proteins, may not get classified into a given gene family.
†
Tandem (T), tandem interspersed (TI), distributed (D).
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